Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

On February 27, the GoodRx Holdings Board Approved a Buyback Program of up to $450.0M

Author: Benzinga Newsdesk | February 29, 2024 07:11am
On February 27, 2024, our board of directors approved a new stock repurchase program (the "New Repurchase Program") that authorized the repurchase of up to $450.0 million of our Class A common stock.

On February 27, 2024, our board of directors approved a new stock repurchase program (the "New Repurchase Program") that authorized the repurchase of up to $450.0 million of our Class A common stock.

Posted In: GDRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist